Newsroom | 22880 results

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. On February 10, 2026, the Compensation Committee of Savara's Board of Directors granted the inducement awards to a new employee who recently joined the Company. The inducement awards consist of options to purchase 7,500 shares of the Company’s common stock and restricted stock units (RSUs)...

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) célèbre la Journée internationale du préservatif (ICD) le 13 février avec un message simple : « Just Use It! », afin de remettre les préservatifs, l’un des outils les plus efficaces et les plus rentables dans la prévention du VIH et des IST, sous les feux de la rampe. Les commémorations organisées dans près de 50 pays par les équipes nationales d’AHF allieront divertissement, créativité et éducation à la distribution gratuite de pré...

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Eradivir Inc., the leading clinical-stage biotech company developing antibody recruiting small molecules to treat disease, today announced EV148 as its development candidate for the treatment of Respiratory Syncytial Virus (RSV). The company is presenting its best-in-class pre-clinical efficacy findings in an oral presentation at RSVVW on February 19, 2026. Globally, RSV affects an estimated 64 million people and causes 160,000 deaths each year. While prev...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Health announced the appointment of Nadege Gunn, MD, CPI, DABOM, FAASLD, as Chief Medical Officer, Hepatology and Obesity....

LOS ANGELES--(BUSINESS WIRE)--De AIDS Healthcare Foundation (AHF) viert Internationale Condoomdag (ICD) op 13 februari met de simpele boodschap: 'Just Use It!' - om condooms, een van de krachtigste en meest kosteneffectieve middelen in de preventie van hiv en soa's, weer in de schijnwerpers te zetten. Wereldwijd zullen bijna 50 AHF-teams in verschillende landen activiteiten organiseren die plezier, creativiteit en voorlichting combineren met de gratis distributie van condooms. Hiermee wordt de...

LOS ANGELES--(BUSINESS WIRE)--'Just Use It!' AHF Celebrates International Condom Day...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Florida Health Dept. Proposes New Formal Rule to Slash HIV Drug Access for Thousands...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025. “Our fourth quarter and full-year results close out a very strong year for Gilead overall, including the successful U.S. launch of Yeztugo, the world’s first twice-yearly HIV prevention therapy, and continued growth for Biktarvy and Descovy,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “In 2026, our potential new la...

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, Inc. (ILiAD), een geavanceerd biotechnologisch bedrijf in de klinische fase dat zich richt op de preventie en behandeling van ziekten veroorzaakt door Bordetella pertussis, heeft vandaag bekendgemaakt dat het een overtekende serie B-financiering van 115 miljoen dollar succesvol heeft afgerond. De financiering werd geleid door RA Capital Management, met deelname van nieuwe investeerders Janus Henderson Investors en BNP Paribas Asset Managemen...

WESTON, Florida--(BUSINESS WIRE)--ILiAD Biotechnologies, Inc. (ILiAD), ein Biotechnologieunternehmen im fortgeschrittenen klinischen Stadium, das sich auf die Prävention und Behandlung von durch Bordetella pertussis verursachten Erkrankungen konzentriert, gab heute den erfolgreichen Abschluss einer überzeichneten Serie-B-Finanzierung in Höhe von 115 Millionen US-Dollar bekannt. Die Finanzierung wurde von RA Capital Management angeführt, unter Beteiligung der neuen Investoren Janus Henderson Inv...